Affiliation:
1. Occupational Cancer Research Centre, Ontario Health, Toronto, ON M5G 2L3, Canada
2. Dalla Lana School of Public Health, University of Toronto, Toronto, ON M5T 3M7, Canada
Abstract
Although a significant body of evidence has attributed certain occupational exposures with leukemia, such as benzene, formaldehyde, 1,3-butadiene and ionizing radiation, more research is needed to identify work environments at increased risk for this disease. Our study aimed to identify occupational and industry groups associated with an elevated incidence of leukemia using a diverse cohort of workers’ compensation claimants from Ontario, Canada. A total of 2,363,818 workers in the Occupational Disease Surveillance System (ODSS) cohort, with claims between 1983–2019, were followed for malignant leukemia diagnoses up to 31 December 2019. We used a Cox proportional-hazards model to estimate the relative incidence of leukemia in specific occupation and industry groups. After adjusting for age and birth year, males in protective services (HR = 1.17, 95% CI = 1.02–1.35), metal machining (HR = 1.23, 95% CI = 1.07–1.41), transport (HR = 1.15, 95% CI = 1.06–1.25), and mining occupations (HR = 1.28, 95% CI = 1.02–1.60) had elevated risks of leukemia compared to other workers in the ODSS, with comparable findings by industry. Among female workers, slight risk elevations were observed among product fabricating, assembling, and repairing occupations, with other increased risks seen in furniture and fixture manufacturing, storage, and retail industries. These findings underscore the need for exposure-based studies to better understand occupational hazards in these settings.
Funder
Ontario Ministry of Labour, Immigration, Training and Skills Development
Ontario Health agency
Reference56 articles.
1. Current Cancer Epidemiology;Mattiuzzi;J. Epidemiol. Glob. Health,2019
2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021
3. Review of Guidelines for the Identification and Clinical Care of Patients with Genetic Predisposition for Hematological Malignancies;Schlegelberger;Fam. Cancer,2021
4. Epidemiology and Etiology of Leukemia and Lymphoma;Bispo;Cold Spring Harb. Perspect. Med.,2020
5. (2024, January 17). International Agency for Research on Cancer Agents Classified by the IARC Monographs, Volumes 1–135—IARC Monographs on the Identification of Carcinogenic Hazards to Humans. Available online: https://monographs.iarc.who.int/agents-classified-by-the-iarc/.